Skip to main content

Table 1 Patients baseline characteristics

From: Comparative analysis of infective endocarditis in hemodialysis versus non-hemodialysis patients in Iran: implications for clinical practice and future research

 

HD Group

(n = 34)

Non-HD Group

(n = 105)

P-value

Age (years) — Mean ± SD

49.85 ± 18.139

45.30 ± 17.4

0.560

Male — No. (%)

23 (67.65%)

66 (62.86%)

0.613

Dialysis Access Type — No. (%)

   

 Arteriovenous fistulae

5 (14.71%)

-

-

 Central venous catheters

27 (79.41%)

-

-

 Both

2 (5.88%)

-

-

Infective Endocarditis Diagnosis — No. (%)

   

 Definite

25 (73.53%)

79 (75.24%)

0.842

  Acute

20 (58.82%)

59 (56.19%)

0.788

  Subacute

2 (5.88%)

19 (18.10%)

0.084

  Chronic

3 (8.82%)

1 (0.95%)

0.017

 Possible

9 (26.47%)

26 (24.76%)

0.842

Past Medical History & Comorbidities — No. (%)

   

 Cerebrovascular Diseases

5 (14.71%)

7 (6.66%)

0.147

 Diabetes Mellitus

13 (38.23%)

17 (16.19%)

0.023

 Hypertension

21 (61.76%)

18 (17.14%)

0.001

 Prior IE

7 (20.58%)

10 (9.52%)

0.087

 IV Drug Abuse

1 (2.94%)

10 (9.52%)

0.217

 Use of Immunosuppressive Agents

4 (11.76%)

4 (3.80%)

0.083

 Rheumatic Heart Diseases

0 (0.0%)

5 (4.76%)

0.195

 Non-rheumatic Valvular Heart Diseases

21 (61.76%)

72 (68.57%)

0.464

  Aortic Regurgitation

7 (20.58%)

10 (6.66%)

0.087

  Aortic Stenosis

1 (2.94%)

3 (2.85%)

0.980

  Mitral Regurgitation

11 (32.35%)

25 (23.80%)

0.323

  Mitral Stenosis

0 (0.0%)

4 (3.80%)

0.248

  Tricuspid Regurgitation

14 (41.17%)

51(48.57%)

0.453

  Tricuspid Stenosis

1 (2.94%)

1 (0.95%)

0397

  Pulmonary Regurgitation

5 (14.70%)

26 (24.76%)

0.212

  Pulmonary Stenosis

0 (0.0%)

2 (1.90%)

0.568

 Congestive Heart Failure

10 (29.41%)

14 (13.33%)

0.033

 History of Cardiac Valve Surgeries

5 (14.7%)

30 (28.57%)

0.105

 History of CABG

3 (8.82%)

2 (1.90%)

0.600

 Congenital Heart Diseases

8 (23.52%)

38 (36.19%)

0.843

 Degenerative Valve Diseases

1 (2.94%)

8 (7.61%)

0.864